The US Testosterone Market DataPack (2016-2020)
The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research.
The market figures and industry dynamics are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.
It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers.
It also explores the competitive landscape of the respective market with focus on major players.
The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.
Our success parameter is very simple - impact of our services on our clients' business. We provide high quality, cost effective research and analysis to support decision making processes for industry professionals. Our strength lies in the reliability of our research and on the value added analysis that we provide.
We have a team of research analysts who have mastered the skill of preparing flawless market intelligence reports to help clients maximize their productivity and return on investment. Our analysts have great expertise to assess current trends in business practices, product promotion and market competition.
The market figures and industry dynamics are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.
It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers.
It also explores the competitive landscape of the respective market with focus on major players.
The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.
Our success parameter is very simple - impact of our services on our clients' business. We provide high quality, cost effective research and analysis to support decision making processes for industry professionals. Our strength lies in the reliability of our research and on the value added analysis that we provide.
We have a team of research analysts who have mastered the skill of preparing flawless market intelligence reports to help clients maximize their productivity and return on investment. Our analysts have great expertise to assess current trends in business practices, product promotion and market competition.
The US Testosterone Market by Value (2013–2018E)
Men Enrolled for Testosterone Therapy by Prior Prescriptions (2014)
The US Testosterone Prescriptions by Volume (2012-2020E)
The US Testosterone Prescriptions Growth Rate (2013-2020E)
Injectable Testosterone Prescriptions by Volume (2012-2020E)
Injectable Testosterone Prescriptions Growth Rate (2013-2020E)
Topical Testosterone Prescriptions by Volume (2012-2020E)
Topical Testosterone Prescriptions Growth Rate (2013-2020E)
Decreasing Testosterone Level of Men with Age
Patients Opting for Testosterone Therapy by Volume in the US (2010-2015E)
Male Patients Opting for Testosterone Therapy by Volume in the US (2010-2015E)
The US Ageing Population (2007-2015E)
The US Healthcare Expenditure Per Capita (2007-2015E)
The US Fertility Rate (1970-2014)
The US Obese Population Growth Rate (2008-2014)
Hypogonadism Prevalence in Percentage by Age Group
Vibex QS T Sales Estimations in the US (2018E-2022E)
Monthly TRX (Oral and Injectable Methotrexate)
OTREXUP Sales by Revenue in the US (2014-2019E)
LPCN 1021 Estimated Sales by Revenue in the US (2016E–2025E)
Axiron Prescription Volumes (TRx) (2015)
Androgel Sales by Revenue in the US (2013-2015)
Total EpiPen Prescriptions in the US (2014-2019E)
Acrux Revenue by Products (2015)
Acrux Revenue by Geography (2015)
Acrux Revenue and Net Income (2011-2015)
Antares Revenue by Segment (2015)
Antares Pharma Revenue and Net Income (2011-2015)
AbbVie Revenue by Products (2015)
AbbVie Revenue by Geography (2015)
AbbVie Revenue and Net Income (2011-2015)
Endo’s Revenue by Segment (2015)
Endo International’s Revenue and Net Income (201
Heart Attack among Men before and after Testosterone Therapy (2014)
Testosterone Products Market Share by Company (2012 -2019E)
Difference between Vibex Quickshot and Intramuscular Injection
Difference between Oral and Injectable Methotrexate
Men Enrolled for Testosterone Therapy by Prior Prescriptions (2014)
The US Testosterone Prescriptions by Volume (2012-2020E)
The US Testosterone Prescriptions Growth Rate (2013-2020E)
Injectable Testosterone Prescriptions by Volume (2012-2020E)
Injectable Testosterone Prescriptions Growth Rate (2013-2020E)
Topical Testosterone Prescriptions by Volume (2012-2020E)
Topical Testosterone Prescriptions Growth Rate (2013-2020E)
Decreasing Testosterone Level of Men with Age
Patients Opting for Testosterone Therapy by Volume in the US (2010-2015E)
Male Patients Opting for Testosterone Therapy by Volume in the US (2010-2015E)
The US Ageing Population (2007-2015E)
The US Healthcare Expenditure Per Capita (2007-2015E)
The US Fertility Rate (1970-2014)
The US Obese Population Growth Rate (2008-2014)
Hypogonadism Prevalence in Percentage by Age Group
Vibex QS T Sales Estimations in the US (2018E-2022E)
Monthly TRX (Oral and Injectable Methotrexate)
OTREXUP Sales by Revenue in the US (2014-2019E)
LPCN 1021 Estimated Sales by Revenue in the US (2016E–2025E)
Axiron Prescription Volumes (TRx) (2015)
Androgel Sales by Revenue in the US (2013-2015)
Total EpiPen Prescriptions in the US (2014-2019E)
Acrux Revenue by Products (2015)
Acrux Revenue by Geography (2015)
Acrux Revenue and Net Income (2011-2015)
Antares Revenue by Segment (2015)
Antares Pharma Revenue and Net Income (2011-2015)
AbbVie Revenue by Products (2015)
AbbVie Revenue by Geography (2015)
AbbVie Revenue and Net Income (2011-2015)
Endo’s Revenue by Segment (2015)
Endo International’s Revenue and Net Income (201
Heart Attack among Men before and after Testosterone Therapy (2014)
Testosterone Products Market Share by Company (2012 -2019E)
Difference between Vibex Quickshot and Intramuscular Injection
Difference between Oral and Injectable Methotrexate
